Utama › Kanser Salur Empedu (Kolangiokarsinoma)
Kajian klinikal Kanser Salur Empedu (Kolangiokarsinoma) sedang mengambil peserta di AS
56 kajian untuk Kanser Salur Empedu (Kolangiokarsinoma) sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX13 kajian
- New York City, NY11 kajian
- Boston, MA8 kajian
- Rochester, MN7 kajian
- Arlington, VA7 kajian
- Los Angeles, CA7 kajian
- Chicago, IL7 kajian
- Columbus, OH6 kajian
- Cleveland, OH6 kajian
- Edison, NJ5 kajian
- Queens, NY5 kajian
- Grand Rapids, MI5 kajian
- Nashville, TN5 kajian
- San Antonio, TX5 kajian
- Philadelphia, PA5 kajian
- Tampa, FL5 kajian
- Mountain View, CA5 kajian
- Washington, DC5 kajian
- Baldwin Park, CA5 kajian
- Baltimore, MD5 kajian
- Dallas, TX5 kajian
- Miami, FL5 kajian
- Orange, CA4 kajian
- St. Louis, MO4 kajian
- Durham, NC4 kajian
- Seattle, WA4 kajian
- Detroit, MI4 kajian
- New Haven, CT4 kajian
- Atlanta, GA3 kajian
- West Valley City, UT3 kajian
- Jacksonville, FL3 kajian
- Salt Lake City, UT3 kajian
- Buffalo, NY3 kajian
- Birmingham, AL3 kajian
- San Francisco, CA3 kajian
- Louisville, KY3 kajian
- Santa Monica, CA3 kajian
Mengikut negeri
- Alabama3 kajian
- Arizona3 kajian
- California20 kajian
- Colorado3 kajian
- Connecticut6 kajian
- Florida13 kajian
- Georgia3 kajian
- Illinois8 kajian
- Kentucky4 kajian
- Maryland9 kajian
- Massachusetts10 kajian
- Michigan8 kajian
- Minnesota10 kajian
- Missouri5 kajian
- New Jersey8 kajian
- New York15 kajian
- North Carolina6 kajian
- Ohio10 kajian
- Pennsylvania5 kajian
- Tennessee5 kajian
- Texas15 kajian
- Utah6 kajian
- Virginia10 kajian
- Washington4 kajian
- Wisconsin4 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06728410Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT03942328Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Mengambil pesertaKajian pemerhatian
Umur 2 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT01915225A Study of PHST001 in Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06270706Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04645160PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Mengambil pesertaFasa 2
Umur 18 hingga 120 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05286814A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07265674[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07673341Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06302621Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Mengambil pesertaFasa 2
Umur 19 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07146646A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07488676Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06282575Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07780838Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05732831Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07282912Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT05497531AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07619313Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04891289HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT06899152Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT07486713TCR1188-ABC Cells in KRAS-mutated Cancers
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07594067Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT05285358D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT06622057Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.